NDC 69680-185 – Memantine hydrochloride and donepezil hydrochloride
Memantine Hydrochloride 28 mg/1; Donepezil Hydrochloride 10 mg/1 · Capsule, Extended Release · Oral
Product NDC69680-185
Product details
- Brand name
- Memantine hydrochloride and donepezil hydrochloride
- Generic name
- Memantine hydrochloride and donepezil hydrochloride
- Labeler
- Vitruvias Therapeutics, Inc.
- Dosage form
- Capsule, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA216901
- Marketed since
- July 16, 2025
- Listing expires
- December 31, 2026
- Pharmacologic class
- Cholinesterase Inhibitor; N-methyl-D-aspartate Receptor Antagonist
Active ingredients
- Memantine Hydrochloride 28 mg/1
- Donepezil Hydrochloride 10 mg/1
Uses, dosage, side effects and warnings for Memantine hydrochloride and donepezil hydrochloride →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 69680-185-30 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69680-185-30) | Jul 16, 2025 |
Other Memantine hydrochloride and donepezil hydrochloride products
- 69680-183 Memantine Hydrochloride 14 mg/1; Donepezil Hydrochloride 10 mg/1 · Capsule, Extended Release · Vitruvias Therapeutics, Inc.